@article{article, title  = {{DOC-MEK: A double-blind randomized phase II trial of docetaxel with or without selumetinib (AZD6244; ARRY-142886) in wt BRAF advanced melanoma.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{}},

 year = {{2013}},

 month = {{5}},

 author = {{Gupta A and Love S and Schuh A and Collins L and Thomason A and Asher R and Lisle R and Churchman M and Shanyinde M and Plummer R and Nathan PD et al}},

 doi = {{10.1200/jco.2013.31.15_suppl.9068}},

 volume = {{31}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{15_suppl}},

 pages = {{9068-9068}},

 note = {{Accessed on 2025/01/03}}}